Yarrow Bioscience, Inc. (YARW)
NASDAQ · Manufacturing · Pharmaceutical preparations
$25.54−$0.5300 (−2.03%) on the dayAs of the close; data may be delayed.
YARW price, last 12 months
Key stats
- Previous close
- $26.07
- Open
- $26.98
- Day range
- $25.01 – $27.13
- 52-week range
- $24.00 – $44.28
- Volume
- 100K
- Avg volume (20 days)
- 148.9K
- Market cap
- $215.5M
Performance
1W−12.8%
1M−35.6%
3M—
6M—
YTD—
1Y—
Technicals and fundamentals
About Yarrow Bioscience, Inc.
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $215.5M